Loomis, Sayles & Company
INVA icon

Loomis, Sayles & Company’s Innoviva INVA Stock Holding History

Loomis, Sayles & Company’s Portfolio INVA Stock Details INVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-923
Closed -$13K – 657
2019
Q1 		$13K Sell
923
-540
-37% -$8.74K ﹤0.01% 704
2018
Q4 		$26K Sell
1,463
-698
-32% -$11.3K ﹤0.01% 638
2018
Q3 		$33K Hold
2,161
– – ﹤0.01% 652
2018
Q2 		$30K Buy
+2,161
New +$32.4K ﹤0.01% 714
2017
Q1 		– Sell
-423
Closed -$5K – 995
2016
Q4 		$5K Hold
423
– – ﹤0.01% 905
2016
Q3 		$5K Hold
423
– – ﹤0.01% 872
2016
Q2 		$4K Buy
+423
New +$5K ﹤0.01% 887

Other funds holding INVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company's INVA Position: Q2 2019 in Review

Loomis, Sayles & Company sold out of Innoviva (INVA) in Q2 2019, closing a stake of 923 shares — an estimated $13K sold.

Loomis, Sayles & Company first reported a position in INVA in Q2 2016 and held it in 7 quarters. The position peaked at $33K in Q3 2018. 217 funds tracked by Wall St. Rank hold INVA as of Q2 2019.

  • Loomis, Sayles & Company reported no remaining Innoviva position as of Q2 2019 after selling out during the quarter.
  • Loomis, Sayles & Company sold 923 Innoviva shares in Q2 2019, an estimated $13K.
  • Loomis, Sayles & Company first reported a position in Innoviva in Q2 2016 and held it in 7 quarters.
  • Loomis, Sayles & Company's Innoviva position peaked at $33K in Q3 2018.
  • 217 funds tracked by Wall St. Rank held Innoviva as of Q2 2019.

Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.